$14.43

Latest weekly close · Market cap $4.7B

Share CORZ P/S history

Within its usual range

Core Scientific's P/S of 10.7x is higher than 52% of its weekly readings since January 2024 (as of ).

  • Forward P/E 92.2× (analyst estimates, not ranked).
  • No P/E: earnings over the last twelve months are negative.
  • No EV/EBITDA: recent financial data is missing.

Weekly P/S since January 2024

P/S each weekMiddle half of its readingsMedian 10.0×
P/S weekly history0×10×20×30×10.7×202420252026
Median
10.0×
Low to high
1.8× to 26.5×
Versus median
+7%
History starts
January 2024

P/S

52ndpercentile

of its weekly readings since January 2024

Growth, last 12 months vs the year before

Revenue
+26%accelerating
EPS
n/m

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading
-6,000-4,000-2,00002,000202420252026

P/S at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

CORZ P/S at each year-end
Year-endP/S5-year percentileP/EEV/SalesEV/EBITDA
15.2×89n/m13.9×n/m
8.1×87n/m7.6×29.8×

Loading peers and related research…

About this history

What is CORZ's current P/S?
Core Scientific's P/S of 10.7x is higher than 52% of its weekly readings since January 2024 (as of Oct 30, 2026).
What is CORZ's five-year median P/S?
10.0x. Half of CORZ's weekly readings since January 2024 were higher and half were lower. This page has 145 weekly readings, from Jan 22, 2024 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank compares CORZ only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Source: SEC company filings and weekly market prices. Multiples use the last twelve months of financial results. Updated .

How the valuation data is built